Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $129,503 | $99,219 | $81,504 | $65,846 |
Gross Profit | 117,815 | 90,534 | 74,012 | 57,016 |
EBITDA | 18,387 | 11,123 | -11,952 | -18,667 |
EBIT | 10,561 | -12,515 | -21,799 | |
Net Income | 17,395 | 7,410 | -15,886 | -25,060 |
Net Change In Cash | 129,503 | 99,219 | 81,504 | 65,846 |
Free Cash Flow | 26,185 | -1,754 | 246 | -30,988 |
Cash | 42,907 | 47,120 | 73,048 | 53,104 |
Basic Shares | 135,635 | 132,885 | 126,997 | 126,037 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $376,072 | $196,542 | $59,606 | $3,686 |
Gross Profit | 339,377 | 177,414 | 54,619 | 2,932 |
EBITDA | -12,227 | -109,625 | -227,434 | -294,553 |
EBIT | -112,224 | -229,315 | -295,806 | |
Net Income | -16,141 | -140,039 | -262,140 | -311,458 |
Net Change In Cash | 376,072 | 196,542 | 59,606 | 3,686 |
Free Cash Flow | -6,311 | -112,301 | -247,485 | -280,998 |
Cash | 42,907 | 71,335 | 88,398 | 53,641 |
Basic Shares | 127,234 | 120,958 | 69,305 | 55,032 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.13 |
2025-09-30 | $0.06 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.20 |
